Tau-PET showed deposition in neocortical regions consistent with biological stage C. Clinically, he presented with early mild dementia (clinical stage 4), which is more advanced than typically expected for biological stage C. This staging mismatch prompted further investigation into comorbidities. This evidence concerns the gene MAPT and dementia.